Best Chemotherapy doctors in Israel: TOP 28 doctors

Leading expert in sarcoma and orthopedic oncology with extensive research and clinical experience at Sourasky Medical Center.

• Head of the Soft Tissue and Bone Oncology Unit since 2000
• Fellowship-trained at Institut Gustave Roussy, Paris
• Member of the ESMO Sarcoma group faculty
• Pioneering work in tumor immunology research
• Former chairman of the Israeli Society for Oncology and Radiotherapy

Dr. Pelles Sharon specializes in advanced chemotherapy techniques, including Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at Sourasky Medical Center.

• Expert in immunotherapy and targeted therapy for various cancers
• Conducted clinical research on patient attitudes toward trials
• Performs complex procedures like Whipple surgery and liver resections
• Offers multiple chemotherapy approaches tailored to cancer type

Dr. Sarid is a seasoned oncologist at Sourasky Medical Center with 38 years of experience specializing in chemotherapy and biological cancer therapy.

• Senior oncologist at Sourasky Medical Center since 2009
• Principal investigator of clinical trials in cancer therapies
• Author of 30+ articles on cancer treatment
• Member of The European Society for Medical Oncology and The American Society of Clinical Oncology
• Educated at Oxford University with a specialty in cancer urology

Specialist in Oncological Gynecology and Radiotherapy – Tamar Sapra brings focused expertise to chemotherapy treatment at Sourasky Medical Center (Ichilov).

• Specializes in gynecological oncology cases
• Combines chemotherapy with radiotherapy for comprehensive care
• Works at one of Israel's leading medical centers

Prof. Amit Tirosh heads Sheba Medical Center's Neuroendocrine Tumors Service and leads research in endocrine oncology with international collaborations.

• Specializes in hereditary NET syndromes like MEN1 and VHL
• Trained at National Institutes of Health in endocrine tumor genetics
• 40+ publications on NET treatments in top medical journals
• Provides advanced therapies including peptide NPVfgsnerceptor radionuclide therapy
• Member of European Neuroendocrine Tumors Society

Head of the Medical Oncology Division at Sourasky Medical Center – Dr. Wolf specializes in advanced chemotherapy treatments.

• Extensive experience in oncology and internal medicine
• Degree from Ben Gurion University of the Negev
• Former service in Army Medical Units
• Fluent in English for international patients

Dr. Ari Raphael leads groundbreaking research in lung and breast cancer at Sourasky Medical Center, with a focus on genomic medicine and immunotherapy.

• Primary investigator for clinical trials on pembrolizumab and neoadjuvant immunotherapy
• Expert in comprehensive genomic profiling and liquid biopsies
• Moderates the Molecular Tumor Board for the Israeli Lung Cancer Society
• Outstanding teacher at Tel-Aviv University's Faculty of Medicine

Dr. Dvora Blumental has led neuro-oncology services at top institutions like Huntsman Cancer Institute and Sourasky Medical Center.

• Specializes in neuro-oncology with 30 years of experience of experience
• Trained at Memorial Sloan-Kettering Cancer Center
• Director of Neuro-oncology Service at Oncology Institute
• Expert in treating brain and nervous system cancers

Dr. Michael Shapira specializes in Bone Marrow Transplantation with over 36 years of experience of experience since graduating from Hebrew University Medical School.

• Senior physician in the Bone Marrow Transplantation department at Hadassah Medical Center
• Trained in internal medicine at Hadassah Medical Center
• Fluent in English and Hebrew for comfortable patient communication

Dr. Fredi Aviv brings 34 years of experience of specialized experience in oncohematology at Sourasky Medical Center.

• Specializes in chemotherapy for blood-related cancers
• Practices at one of Israel's leading medical centers
• Board-certified in oncohematology

Director of oncology hospitalization at Tel Aviv Medical Center – Dr. Stepfansky leads a dedicated oncology team at Ichilov.

• Over 26 years of experience of experience in oncology
• Specialized in internal medicine before focusing on oncology
• Primary researcher in phase I-III clinical trials
• Trained at Tel Aviv Medical Center's prestigious oncology program

Dr. Dror Levin specializes in pediatric hematology oncology, focusing on bone cancer (sarcoma) in children. He leads the children's hematology oncology department at Sourasky Medical Center in Tel Aviv.

• Senior pediatrician at Children's Hospital 'Dana'
• Specialized in pediatric hematology and oncology at Schneider Children's Medical Center
• Trained in oncology bone and soft tissue at Rizzoli Orthopaedic Institute in Italy
• Member of the Israeli association for pediatric hemato-oncology (ISPHO)

Dr. Sonnenblick specializes in breast cancer treatments, including chemotherapy, radiotherapy, and targeted therapies like Keytruda. He has presented at over 30 national and international scientific meetings.

• Recipient of multiple awards, including ESMO Breast Cancer Translational Research Award
• Member of prestigious oncology societies like ESMO and EACR
• Fellowship-trained in breast cancer research at Emory University and Jules Bordet Institute

Dr. Ivetta Danylesko specializes in chemotherapy at Sheba Medical Center, bringing expert care tailored to individual patient needs.

• Specializes in chemotherapy protocols
• Practices at Sheba Medical Center, a top-tier facility
• Focuses on personalized treatment approaches

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Prof. Ben Boursi leads research on microbiome prognostic factors in cancer therapies – merging cutting-edge science with clinical oncology at Sheba Medical Center.

• Specializes in gastrointestinal cancers with focused training at University of Pennsylvania and MD Anderson
• Founder of ECOG-ACRIN Microbiome Working Group – pioneering microbial modulation treatments
• Develops predictive models for colorectal and pancreatic cancers undergoing clinical trials
• Board-certified in both Internal Medicine and Medical Oncology by Israeli medical boards
• Teaches host-microbiome interactions at Tel Aviv University's medical school

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.